Skip to main content

Advertisement

Log in

Tumour cell migration in adamantinomatous craniopharyngiomas is promoted by activated Wnt-signalling

  • Original Paper
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

Abstract

Activating β-catenin mutations with aberrant cytoplasmic and nuclear protein accumulation are hallmarks of adamantinomatous craniopharyngiomas (adaCP). These tumours tend to be associated with unfavourable and occasionally disastrous sequelae, as they invade adjacent brain structures such as the hypothalamus. The peculiar digitate growth pattern does not always allow gross surgical removal often leading to recurrence. The tips of invading adaCP epithelium harbour cell clusters with nuclear β-catenin accumulations, suggesting an influence of β-catenin-dependent signal transduction on the tumour migratory capacity. This hypothesis was tested by suppressing β-catenin expression in six primary human adaCP cell cultures using small interfering RNA (siRNA) directed against the β-catenin gene (CTNNB1). Tumour cell migration was significantly reduced in Boyden chamber and wound-healing experiments following siRNA treatment. We further showed that fascin, a target gene of β-catenin TCF signalling in colorectal cancer cells and a key component of filopodia, is also involved in this process. β-Catenin accumulating tumour cells co-express fascin and fascin mRNA levels can be significantly down-regulated in adaCP cultures treated with CTNNB1 siRNA. Furthermore, migration experiments showed a significantly lower cell motility of adaCP tumour cells in vitro when transfected with fascin siRNA. This suggests that activated Wnt-signalling serves as a promoter of the epithelial migration machinery by regulating target molecules such as fascin in adaCP tumour cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Behrens J, Jerchow BA, Wurtele M et al (1998) Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. Science 280:596–599

    Article  CAS  PubMed  Google Scholar 

  2. Behrens J, Lustig B (2004) The Wnt connection to tumorigenesis. Int J Dev Biol 48:477–487

    Article  CAS  PubMed  Google Scholar 

  3. Behrens J, von Kries JP, Kuhl M et al (1996) Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 382:638–642

    Article  CAS  PubMed  Google Scholar 

  4. Buslei R, Holsken A, Hofmann B et al (2007) Nuclear beta-catenin accumulation associates with epithelial morphogenesis in craniopharyngiomas. Acta Neuropathol 113:585–590

    Article  CAS  PubMed  Google Scholar 

  5. Buslei R, Nolde M, Hofmann B et al (2005) Common mutations of beta-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region. Acta Neuropathol (Berl) 109:589–597

    Article  CAS  Google Scholar 

  6. Chen SF, Lin CY, Chang YC et al (2009) Effects of small interfering RNAs targeting Fascin on gene expression in oral cancer cells. J Oral Pathol Med 38:722–730

    Article  CAS  PubMed  Google Scholar 

  7. Darnel AD, Behmoaram E, Vollmer RT et al (2009) Fascin regulates prostate cancer cell invasion and is associated with metastasis and biochemical failure in prostate cancer. Clin Cancer Res 15:1376–1383

    Article  CAS  PubMed  Google Scholar 

  8. Demir R, Dimmler A, Naschberger E et al (2009) Malignant progression of invasive tumour cells seen in hypoxia present an accumulation of beta-catenin in the nucleus at the tumour front. Exp Mol Pathol 87:109–116

    Article  CAS  PubMed  Google Scholar 

  9. Fahlbusch R, Hofmann BM (2008) Surgical management of giant craniopharyngiomas. Acta Neurochir (Wien) 150:1213–1226

    Article  CAS  Google Scholar 

  10. Fahlbusch R, Honegger J, Paulus W, Huk W, Buchfelder M (1999) Surgical treatment of craniopharyngiomas: experience with 168 patients. J Neurosurg 90:237–250

    Article  CAS  PubMed  Google Scholar 

  11. Gao X, Wu DH (2008) Fascin expression in human epithelial tumors and its clinical significance. Nan Fang Yi Ke Da Xue Xue Bao 28:953–955

    CAS  PubMed  Google Scholar 

  12. Garnett MR, Puget S, Grill J, Sainte-Rose C (2007) Craniopharyngioma. Orphaned J Rare Dis 2:18

    Article  Google Scholar 

  13. Green H, Kehinde O, Thomas J (1979) Growth of cultured human epidermal cells into multiple epithelia suitable for grafting. Proc Natl Accad Sci USA 76:5665–5668

    Article  CAS  Google Scholar 

  14. Growthy A, Hashizume R, Ji H et al (2000) C-erbB-2/ HER-2 upregulates fascin, an actin-bundling protein associated with cell motility, in human breast cancer cell lines. Oncogene 19:4864–4875

    Article  Google Scholar 

  15. Hashimoto Y, Skacel M, Adams JC (2005) Roles of fascin in human carcinoma motility and signaling: prospects for a novel biomarker? Int J Biochem Cell Biol 37:1787–1804

    Article  CAS  PubMed  Google Scholar 

  16. Henderson BR (2000) Nuclear-cytoplasmic shuttling of APC regulates beta-catenin subcellular localization and turnover. Nat Cell Biol 2:653–660

    Article  CAS  PubMed  Google Scholar 

  17. Hofmann BM, Kreutzer J, Saeger W et al (2006) Nuclear beta-catenin accumulation as reliable marker for the differentiation between cystic craniopharyngiomas and rathke cleft cysts: a clinico-pathologic approach. Am J Surg Pathol 30:1595–1603

    Article  PubMed  Google Scholar 

  18. Holsken A, Kreutzer J, Hofmann BM et al (2009) Target gene activation of the Wnt signaling pathway in nuclear beta-catenin accumulating cells of adamantinomatous craniopharyngiomas. Brain Pathol 19:357–364

    Article  PubMed  Google Scholar 

  19. Hulsken J, Birchmeier W, Behrens J (1994) E-cadherin and APC compete for the interaction with beta-catenin and the cytoskeleton. J Cell Biol 127:2061–2069

    Article  CAS  PubMed  Google Scholar 

  20. Iguchi T, Aishima S, Umeda K et al (2009) Fascin expression in progression and prognosis of hepatocellular carcinoma. J Surg Oncol 100:575–579

    Article  PubMed  Google Scholar 

  21. Jamora C, DasGupta R, Kocieniewski P, Fuchs E (2003) Links between signal transduction, transcription and adhesion in epithelial bud development. Nature 422:317–322

    Article  CAS  PubMed  Google Scholar 

  22. Karavitaki N, Brufani C, Warner JT et al (2005) Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up. Clin Endocrinol (Oxf) 62:397–409

    Article  CAS  Google Scholar 

  23. Karavitaki N, Cudlip S, Adams CB, Wass JA (2006) Craniopharyngiomas. Endocr Rev 27:371–397

    Article  PubMed  Google Scholar 

  24. Kato K, Nakatani Y, Kanno H et al (2004) Possible linkage between specific histological structures and aberrant reactivation of the Wnt pathway in adamantinomatous craniopharyngioma. J Pathol 203:814–821

    Article  CAS  PubMed  Google Scholar 

  25. Mattila PK, Lappalainen P (2008) Filopodia: molecular architecture and cellular functions. Nat Rev Mol Cell Biol 9:446–454

    Article  CAS  PubMed  Google Scholar 

  26. Muller T, Bain G, Wang X, Papkoff J (2002) Regulation of epithelial cell migration and tumor formation by beta-catenin signaling. Exp Cell Res 280:119–133

    Article  PubMed  Google Scholar 

  27. Nelson WJ, Nusse R (2004) Convergence of Wnt, beta-catenin, and cadherin pathways. Science 303:1483–1487

    Article  CAS  PubMed  Google Scholar 

  28. Oikonomou E, Barreto DC, Soares B, De Marco L, Buchfelder M, Adams EF (2005) Beta-catenin mutations in craniopharyngiomas and pituitary adenomas. J Neurooncol 73:205–209

    Article  CAS  PubMed  Google Scholar 

  29. Okada K, Shimura T, Asakawa K et al (2007) Fascin expression is correlated with tumor progression of extrahepatic bile duct cancer. Hepatogastroenterology 54:17–21

    CAS  PubMed  Google Scholar 

  30. Orsulic S, Huber O, Aberle H, Arnold S, Kemler R (1999) E-cadherin binding prevents beta-catenin nuclear localization and beta-catenin/LEF-1-mediated transactivation. J Cell Sci 112(Pt 8):1237–1245

    CAS  PubMed  Google Scholar 

  31. Parsons M, Adams JC (2008) Rac regulates the interaction of fascin with protein kinase C in cell migration. J Cell Sci 121:2805–2813

    Article  CAS  PubMed  Google Scholar 

  32. Pereira AM, Schmid EM, Schutte PJ et al (2005) High prevalence of long-term cardiovascular, neurological and psychosocial morbidity after treatment for craniopharyngioma. Clin Endocrinol (Oxf) 62:197–204

    Article  Google Scholar 

  33. Sartoretti-Schefer S, Wichmann W, Aguzzi A, Valavanis A (1997) MR differentiation of adamantinous and squamous-papillary craniopharyngiomas. Am J Neuroradiol 18:77–87

    CAS  PubMed  Google Scholar 

  34. Sekine S, Shibata T, Kokubu A et al (2002) Craniopharyngiomas of adamantinomatous type harbor beta-catenin gene mutations. Am J Pathol 161:1997–2001

    CAS  PubMed  Google Scholar 

  35. Sekine S, Takata T, Shibata T et al (2004) Expression of enamel proteins and LEF1 in adamantinomatous craniopharyngioma: evidence for its odontogenic epithelial differentiation. Histopathology 45:573–579

    Article  CAS  PubMed  Google Scholar 

  36. Tao YS, Edwards RA, Tubb B, Wang S, Bryan J, McCrea PD (1996) Beta-catenin associates with the actin-bundling protein fascin in a noncadherin complex. J Cell Biol 134:1271–1281

    Article  CAS  PubMed  Google Scholar 

  37. Viac J, Reano A, Brochier J, Staquet MJ, Thivolet J (1983) Reactivity pattern of a monoclonal antikeratin antibody (KL1). J Invest Dermatol 81:351–354

    Article  CAS  PubMed  Google Scholar 

  38. Vignjevic D, Schoumacher M, Gavert N et al (2007) Fascin, a novel target of beta-catenin-TCF signaling, is expressed at the invasive front of human colon cancer. Cancer Res 67:6844–6853

    Article  CAS  PubMed  Google Scholar 

  39. Wong NA, Pignatelli M (2002) Beta-catenin—a linchpin in colorectal carcinogenesis? Am J Pathol 160:389–401

    CAS  PubMed  Google Scholar 

  40. Yamashiro S, Yamakita Y, Ono S, Matsumura F (1998) Fascin, an actin-bundling protein, induces membrane protrusions and increases cell motility of epithelial cells. Mol Biol Cell 9:993–1006

    CAS  PubMed  Google Scholar 

  41. Yildiz L, Kefeli M, Aydin O, Kandemir B (2009) Fascin expression in melanocytic lesions of the skin. Eur J Dermatol 19:445–450

    PubMed  Google Scholar 

Download references

Acknowledgments

We thank Verena Schmidt for her excellent technical assistance. Additionally, we are indebted to Nadine Schmiedel, Diana Maron, Silke Sterner and Katharina Porsche for performing immunohistochemical stainings and Jeremy Wiles for proof-reading the manuscript. This work was supported by the ELAN fund (08.09.08.1) of the University Hospital Erlangen (to AH and RB).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rolf Buslei.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (TIFF 13,823 kb)

Supplementary material 2 (TIFF 22,133 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hölsken, A., Buchfelder, M., Fahlbusch, R. et al. Tumour cell migration in adamantinomatous craniopharyngiomas is promoted by activated Wnt-signalling. Acta Neuropathol 119, 631–639 (2010). https://doi.org/10.1007/s00401-010-0642-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00401-010-0642-9

Keywords

Navigation